CASI Pharmaceuticals (CASI) Short Interest Ratio & Short Volume $1.37 -0.06 (-4.20%) As of 12:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CASI Pharmaceuticals Short Interest DataCASI Pharmaceuticals (CASI) has a short interest of 13,100 shares, representing 0.33% of the float (the number of shares available for trading by the public). This marks a -35.78% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 48,899 shares to cover all short positions.Current Short Interest13,100 sharesPrevious Short Interest20,400 sharesChange Vs. Previous Month-35.78%Dollar Volume Sold Short$24.10 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares12,299,000 sharesFloat Size3,920,000 sharesShort Percent of Float0.33%Today's Trading Volume3,766 sharesAverage Trading Volume48,899 sharesToday's Volume Vs. Average8% Short Selling CASI Pharmaceuticals? Sign up to receive the latest short interest report for CASI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCASI Short Interest Over TimeCASI Days to Cover Over TimeCASI Percentage of Float Shorted Over Time CASI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202513,100 shares $24.10 thousand -35.8%0.3%0.1 $1.84 5/31/202520,400 shares $38.96 thousand +20.7%0.5%2.1 $1.91 5/15/202516,900 shares $30.59 thousand +62.5%0.3%1.8 $1.81 4/30/202510,400 shares $20.18 thousand -46.9%0.2%1.1 $1.94 4/15/202519,600 shares $38.04 thousand +2.6%0.4%1.6 $1.94 3/31/202519,100 shares $41.26 thousand -18.0%0.4%1.3 $2.16 3/15/202523,300 shares $51.35 thousand -15.0%0.5%1.1 $2.20 2/28/202527,400 shares $61.65 thousand -24.1%0.6%0.9 $2.25 2/15/202536,100 shares $90.25 thousand -2.7%0.8%1 $2.50 1/31/202537,100 shares $91.64 thousand +17.0%0.8%1 $2.47 Get the Latest News and Ratings for CASI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/202531,700 shares $80.52 thousand -48.0%0.8%0.7 $2.54 12/31/202461,000 shares $172.63 thousand +43.5%1.6%1.3 $2.83 12/15/202442,500 shares $132.18 thousand -4.9%1.1%1 $3.11 11/30/202444,700 shares $169.86 thousand -0.5%1.2%1.2 $3.80 11/15/202444,900 shares $239.32 thousand -40.6%1.2%1.5 $5.33 10/31/202475,600 shares $452.84 thousand -31.3%1.9%2.8 $5.99 10/15/2024110,000 shares $613.80 thousand -24.9%2.6%4.1 $5.58 9/30/2024146,500 shares $873.14 thousand -9.4%3.4%4.3 $5.96 9/15/2024161,700 shares $1.16 million -2.9%3.8%0.7 $7.17 8/31/2024166,600 shares $1.10 million -3.1%3.9%0.7 $6.59 8/15/2024172,000 shares $1.13 million -15.1%4.0%0.7 $6.56 7/31/2024202,600 shares $1.47 million -6.9%3.2%0.8 $7.25 7/15/2024217,600 shares $1.36 million -58.9%3.4%0.9 $6.25 6/30/2024529,600 shares $2.91 million +771.1%8.2%2.3 $5.50 6/15/202460,800 shares $189.09 thousand -23.7%0.9%1.1 $3.11 5/31/202479,700 shares $307.96 thousand +50.1%1.3%2 $3.86 5/15/202453,100 shares $180.01 thousand +14.7%0.8%0.3 $3.39 4/30/202446,300 shares $106.49 thousand -25.9%0.7%0.2 $2.30 4/15/202462,500 shares $153.13 thousand -24.0%1.0%0.3 $2.45 3/31/202482,200 shares $296.74 thousand -35.4%1.3%0.4 $3.61 3/15/2024127,300 shares $404.81 thousand +204.6%2.2%0.7 $3.18 2/29/202441,800 shares $233.66 thousand -21.3%0.7%0.2 $5.59 2/15/202453,100 shares $323.38 thousand +0.8%0.9%1.1 $6.09 1/31/202452,700 shares $361.52 thousand +10.0%0.9%1 $6.86 1/15/202447,900 shares $291.23 thousand +74.8%0.8%0.9 $6.08 12/31/202327,400 shares $196.18 thousand -18.7%0.5%0.5 $7.16 12/15/202333,700 shares $206.58 thousand -58.4%0.6%0.6 $6.13 11/30/202381,000 shares $452.79 thousand -46.4%1.4%1.9 $5.59 11/15/2023151,200 shares $657.72 thousand -33.0%2.5%4.9 $4.35 10/31/2023225,700 shares $911.83 thousand +0.6%3.4%9 $4.04Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.We recently interviewed Rickards to get the full story and understand how everyday Americans can pre 10/15/2023224,400 shares $587.93 thousand -2.6%3.4%12 $2.62 9/30/2023230,400 shares $589.82 thousand -1.5%3.5%15.8 $2.56 9/15/2023233,900 shares $493.53 thousand -1.6%3.5%22.1 $2.11 8/31/2023237,600 shares $548.86 thousand -1.4%3.6%9.1 $2.31 8/15/2023241,000 shares $535.02 thousand +2.4%3.6%8.1 $2.22 7/31/2023235,300 shares $571.78 thousand -3.6%3.5%7.7 $2.43 7/15/2023244,100 shares $646.87 thousand -2.6%3.7%8.2 $2.65 6/30/2023250,700 shares $624.24 thousand -7.4%3.8%6.9 $2.49 6/15/2023270,800 shares $557.85 thousand +12.6%4.1%5.2 $2.06 5/31/2023240,500 shares $678.21 thousand -5.1%3.4%6.5 $2.82 5/15/2023253,300 shares $640.65 thousand -0.7%3.6%7.3 $2.53 4/30/2023255,200 shares $730.38 thousand -5.0%3.6%7.3 $2.86 4/15/2023268,700 shares $964.63 thousand +6.5%3.6%7.1 $3.59 3/31/2023252,200 shares $585.10 thousand +3.4%2.7%6.4 $2.32 3/15/2023244,000 shares $417.24 thousand -6.1%2.6%9.1 $1.71 2/28/2023259,700 shares $501.22 thousand -1.7%2.8%8.3 $1.93 2/15/2023264,300 shares $509.78 thousand +0.9%2.2%8 $1.93 1/31/2023262,000 shares $534.48 thousand -5.7%2.0%7.8 $2.04 1/15/2023277,800 shares $548.66 thousand -5.9%2.1%8.2 $1.98 12/30/2022295,200 shares $528.41 thousand +44.1%2.3%8.7 $1.79 12/15/2022204,900 shares $370.87 thousand +77.6%1.6%5.5 $1.81 11/30/2022115,400 shares $229.65 thousand +27.4%0.9%2.6 $1.99 11/15/202290,600 shares $176.67 thousand -13.6%0.7%1.6 $1.95 10/31/2022104,900 shares $206.65 thousand -9.6%1.0%0.6 $1.97 10/15/2022116,000 shares $257.52 thousand +26.2%1.1%0.6 $2.22 9/30/202291,900 shares $238.94 thousand -41.5%0.9%0.4 $2.60 9/15/2022157,200 shares $664.96 thousand +28.9%1.5%0.7 $4.23 8/31/2022122,000 shares $457.50 thousand -57.1%1.2%0.6 $3.75 8/15/2022284,500 shares $1.14 million +94.5%2.7%1.3 $4.02 7/31/2022146,300 shares $361.36 thousand -18.8%1.4%1.5 $2.47 7/15/2022180,100 shares $491.67 thousand -14.9%1.7%2.5 $2.73 6/30/2022211,700 shares $605.46 thousand +28.9%2.0%3.1 $2.86 6/15/2022164,300 shares $509.33 thousand +89.9%1.8%2.4 $3.10 5/31/202286,500 shares $297.56 thousand -85.9%N/A1.4 $3.44 5/15/2022612,700 shares $213.53 thousand +2.1%0.7%1.8 $0.35 4/30/2022600,200 shares $258.09 thousand -5.2%0.7%1.5 $0.43 4/15/2022633,400 shares $393.34 thousand -26.7%0.7%1.3 $0.62 3/31/2022863,900 shares $699.50 thousand -10.8%1.0%1.4 $0.81 3/15/2022968,800 shares $773.97 thousand -19.3%1.1%1.5 $0.80 2/28/20221,200,000 shares $1.01 million -4.0%1.4%1.6 $0.84 2/15/20221,250,000 shares $1.02 million -22.4%1.4%1.4 $0.82 1/31/20221,610,000 shares $1.08 million +1.9%1.8%1.4 $0.67 1/15/20221,580,000 shares $1.14 million -25.8%N/A1.3 $0.72 12/31/20212,130,000 shares $1.70 million -9.4%2.4%1.7 $0.80 12/15/20212,350,000 shares $1.89 million -27.5%2.7%1.6 $0.80 11/30/20213,240,000 shares $2.90 million +14.5%3.7%1.4 $0.90 11/15/20212,830,000 shares $2.89 million -8.7%3.2%1.2 $1.02 10/29/20213,100,000 shares $3.35 million +12.3%3.5%1.2 $1.08 10/15/20212,760,000 shares $3.17 million +11.7%3.1%1.1 $1.15 9/30/20212,470,000 shares $2.94 million -10.5%2.8%1.1 $1.19Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.We recently interviewed Rickards to get the full story and understand how everyday Americans can pre 9/15/20212,760,000 shares $4.08 million -34.1%3.1%1.3 $1.48 8/31/20214,190,000 shares $6.70 million +28.9%4.7%3.1 $1.60 8/13/20213,250,000 shares $4.26 million +5.5%3.7%2.6 $1.31 7/30/20213,080,000 shares $3.57 million -2.2%3.5%3.4 $1.16 7/15/20213,150,000 shares $4.22 million -2.8%3.5%2.3 $1.34 6/30/20213,240,000 shares $5.02 million -40.1%3.6%2.2 $1.55 6/15/20215,410,000 shares $8.93 million +1.5%6.1%2.6 $1.65 5/28/20215,330,000 shares $8.53 million +24.0%6.0%2.7 $1.60 5/14/20214,300,000 shares $6.11 million +24.3%4.8%2.3 $1.42 4/30/20213,460,000 shares $6.26 million +52.4%3.9%1.9 $1.81 4/15/20212,270,000 shares $4.27 million +8.6%2.7%1.6 $1.88 3/31/20212,090,000 shares $4.16 million +22.9%2.7%1.7 $1.99 3/15/20211,700,000 shares $4.22 million -3.4%2.3%3.3 $2.48 2/26/20211,760,000 shares $4.38 million +6.7%2.4%3.7 $2.49 2/12/20211,650,000 shares $4.95 million -9.8%2.3%3.2 $3.00 1/29/20211,830,000 shares $6.28 million +2.2%2.5%3.9 $3.43 1/15/20211,790,000 shares $5.96 million -3.2%2.5%3.3 $3.33 12/31/20201,850,000 shares $5.48 million -2.1%2.6%4 $2.96 12/15/20201,890,000 shares $4.59 million +1.6%2.6%4.4 $2.43 11/30/20201,860,000 shares $4.50 million +1.1%2.6%4.7 $2.42 11/15/20201,840,000 shares $3.64 million +4.0%2.5%4.8 $1.98 10/30/20201,770,000 shares $3.42 million +22.1%2.4%4.4 $1.93 10/15/20201,450,000 shares $2.48 million -6.5%2.0%3.4 $1.71 9/30/20201,550,000 shares $2.37 million +0.7%2.1%3.1 $1.53 9/15/20201,540,000 shares $2.62 million +19.4%2.1%3.1 $1.70 8/31/20201,290,000 shares $2.21 million -9.8%1.8%2.8 $1.71 8/14/20201,430,000 shares $2.75 million -21.4%2.3%3.3 $1.92 7/31/20201,820,000 shares $3.51 million +9.6%3.8%4.2 $1.93 7/15/20201,660,000 shares $3.49 million -3.5%3.1%6 $2.10 CASI Short Interest - Frequently Asked Questions What is CASI Pharmaceuticals' current short interest? Short interest is the volume of CASI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 13,100 shares of CASI short. 0.33% of CASI Pharmaceuticals' shares are currently sold short. Learn More on CASI Pharmaceuticals' current short interest. Which institutional investors are shorting CASI Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CASI Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for CASI Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.33% of CASI Pharmaceuticals' floating shares are currently sold short. Is CASI Pharmaceuticals' short interest increasing or decreasing? CASI Pharmaceuticals saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 13,100 shares, a decline of 35.8% from the previous total of 20,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CASI Pharmaceuticals' float size? CASI Pharmaceuticals currently has issued a total of 12,299,000 shares. Some of CASI Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CASI Pharmaceuticals currently has a public float of 3,920,000 shares. How does CASI Pharmaceuticals' short interest compare to its competitors? 0.33% of CASI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CASI Pharmaceuticals: Alto Neuroscience, Inc. (12.98%), Clearside Biomedical, Inc. (0.48%), Assertio Holdings, Inc. (6.28%), Metagenomi, Inc. (9.63%), Biomea Fusion, Inc. (24.03%), PMV Pharmaceuticals, Inc. (1.99%), Repare Therapeutics Inc. (1.93%), MediciNova, Inc. (0.35%), Achilles Therapeutics plc (1.26%), PDS Biotechnology Corporation (4.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short CASI Pharmaceuticals stock? Short selling CASI is an investing strategy that aims to generate trading profit from CASI Pharmaceuticals as its price is falling. CASI shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CASI Pharmaceuticals? A short squeeze for CASI Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CASI, which in turn drives the price of the stock up even further. How often is CASI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASI, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Alto Neuroscience Short Squeeze Clearside Biomedical Short Squeeze Assertio Short Squeeze Metagenomi Short Squeeze Biomea Fusion Short Squeeze PMV Pharmaceuticals Short Squeeze Repare Therapeutics Short Squeeze MediciNova Short Squeeze Achilles Therapeutics Short Squeeze PDS Biotechnology Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CASI) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CASI Stock Alerts